The FDA has cleared a multiplex polymerase chain reaction test designed to detect 11 clinically relevant gastrointestinal pathogens from a single stool sample.The Xpert GI Panel (Cepheid) can identify ...
October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...
June 27, 2003 -- A monoclonal antibody stool test is highly predictive of the presence or absence of Helicobacter pylori infection in children, according to the results of a study published in the ...
Each year, close to 2 million people around the world are diagnosed with colorectal cancer and roughly 935,000 people die from it. Scientists say they have developed a new stool test that is more ...
Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...
CHICAGO (Reuters) - Using just a stool sample, doctors may now be able to detect colon and many other cancers of the digestive tract including stomach, pancreatic, bile duct and esophageal cancer, U.S ...
NEW YORK (Reuters Health) - A simplified colorectal cancer screening test that detects tumor DNA in stool is an improvement over an earlier-generation assay, according to North American researchers.
VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results